Skip to main content

Table 2 Dose volume histogram (DVH) parameters in the six pilot institutes (I–VI)

From: Transparency in quality of radiotherapy for breast cancer in the Netherlands: a national registration of radiotherapy-parameters

 

I

II

III

IV

V

VI

Dose to PTV (homogeneity) (%)a

 D98% (SD)

92.0 (3.2)

94.9 (2.2)

95.2 (1.6)

96.0 (1.4)

93.4 (4.9)

95.4 (1.1)

 D2% (SD)

104.0 (0.7)

104.0 (0.6)

104.0 (1.0)

103.0 (0.8)

104.0 (0.8)

104.0 (1.5)

 Dmean (SD)

99.7 (0.7)

100.0 (0.4)

100.0 (0.7)

100.0 (0.9)

100.0 (0.5)

101.0 (0.6)

Dose to OAR (Gy)

 MHD (SD)b

0.8 (0.3)

1.7 (1.2)

1.5 (0.5)

0.9 (0.3)

1.0 (0.2)

1.8 (1.4)

 D2% heart (SD)b

2.8 (1.1)

8.3 (6.5)

7.2 (6.3)

4.1 (3.1)

3.3 (0.9)

13.7 (14.4)

 MLD (SD)a

2.1 (0.5)

2.9 (0.9)

2.8 (0.8)

2.9 (0.7)

2.3 (0.6)

3.3 (1.0)

  1. SD, standard deviation, OAR, Organs at risk, MHD, mean heart dose, MLD, mean lung dose
  2. aPatients who received radiotherapy to the breast only, without a boost
  3. bPatients who received radiotherapy to the left breast only, without a boost